Holen Sie sich die Stockscreener-App
1.17
5.65%
-0.07
Handel nachbörslich:
1.15
-0.02
-1.71%
Decoy Therapeutics Inc Aktie (DCOY) Neueste Nachrichten
Form S-1 Decoy Therapeutics Inc For: 8 October By Investing.com - Investing.com Canada
Decoy Therapeutics Inc (DCOY) Stockholders Plan to Sell 2.37M Sh - GuruFocus
About 10 public companies will meet investors in New York, including Decoy Therapeutics. - Stock Titan
Decoy Therapeutics Completes Warrant Inducement, Raises $3.85 Million in Gross Proceeds - Kalkine Media
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com Canada
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com India
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com UK
A cut from $5.91 to $3.25 brought Decoy Therapeutics (DCOY) cash, plus new rights to buy shares. - Stock Titan
DCOY Stock Volatility Spikes As Traders Track Key Levels - stockstotrade.com
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Benzinga
New stock-buying rights can be used immediately, Decoy says, rather than after a shareholder vote - Stock Titan
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release - PR Newswire
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release - cherokeephoenix.org
Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules - TradingView
An investor is set to pay Decoy Therapeutics $3.85 million for shares - Stock Titan
Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules - PR Newswire
Curvature Securities LLC is acting as the sole placement agent in connection with this warrant inducement transaction. - nasdaq.com
DCOY Stock Slides As Cash-Rich Biotech Tests Key Support - timothysykes.com
Decoy Therapeutics shareholders approve warrant issuance and share reduction - Investing.com
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com Australia
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com India
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com UK
Investors approve new warrants, shrink share pool at Decoy Therapeutics (NASDAQ: DCOY) - Stock Titan
Decoy Therapeutics CEO to present antiviral dru... - Pluang
Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - TMX Newsfile
Decoy Therapeutics Grants 3,900 Shares to Chief Business Officer Marschel Peter Klaus - kalkinemedia.com
Decoy Therapeutics Grants 2,000 Shares to Insider Gauthier Patricia G. at No Cost on August 31, 2026 - kalkinemedia.com
Director at Decoy Therapeutics (DCOY) awarded 2,000 restricted shares vesting in 2027 - Stock Titan
Decoy Therapeutics (DCOY) awards CEO 33,455 restricted shares - Stock Titan
Decoy Therapeutics (DCOY) awards CBO stock at $0 per share - Stock Titan
Decoy Therapeutics (DCOY) CFO granted multi-year stock award - Stock Titan
Chief scientist at Decoy Therapeutics (DCOY) gets 4,216-share stock grant - Stock Titan
Decoy Therapeutics (DCOY) director gets 3,000-share stock grant - Stock Titan
Director at Decoy Therapeutics (DCOY) granted 2,000 shares vesting in 2027 - Stock Titan
Director at Decoy Therapeutics (DCOY) gets 2,000-share grant vesting in 2027 - Stock Titan
Decoy Therapeutics (DCOY) awards 3,000 $0.00 shares to director - Stock Titan
Director at Decoy Therapeutics (DCOY) granted 2,000 restricted shares - Stock Titan
Moody Capital Solutions - TMX Newsfile
Decoy (DCOY) Results Check: EPS Prints Above Forecast in the Current Update; Post-Earnings: The Stock Records a 2.81% DecreaseRevenue Guidance Range - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Shares of Decoy Therapeutics Inc (DCOY) - GuruFocus
Decoy (DCOY) Latest Quarter: The Available Earnings Metric Delivers a Beat on the Day; After Earnings: Shares Rise 0.29% in the Latest SessionRevenue Guidance Range - vinanet.vn
Decoy (DCOY) Trading Levels Update: Adds 1.14% to Close at $3.56 for the Current Session; Chart Reference - vinanet.vn
DCOY Q3 2024 Earnings: Narrower Loss of -136.8 per Share Delivers Positive SurpriseCash Flow Report - vinanet.vn
Decoy Therapeutics (DCOY) Advances 1.42% to $3.58, Holding Above SupportCTA Positioning - vinanet.vn
Armistice Capital (DCOY) discloses 65,503-share, 9.99% holding in Decoy Therapeutics - Stock Titan
Decoy Therapeutics (DCOY) Advances 1.42% to $3.58, Holding Above SupportIV Crush Alert - dars.gov.et
DCOY Q2'26 Earnings: EPS estimate is (2.88) USD - TradingView
Decoy Therapeutics: Q2 Earnings Snapshot - Barchart.com
Decoy Therapeutics: Q2 Earnings Snapshot | Associated Press | syndication news - Enidnews.com
Decoy Therapeutics: Q2 Earnings Snapshot - KING5.com
6.10%
5.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):